Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11377440 Modulators of stimulator of interferon genes (STING)

Patent 11377440 was granted and assigned to GlaxoSmithKline on July, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

GlaxoSmithKline

Current Assignee

GlaxoSmithKline

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113774400

Patent Inventor Names

Joshi M. Ramanjulu0

Junya Qu0

Lara Kathryn Leister0

Mark J. Schulz0

Mukesh K. Mahajan0

Stuart Paul Romeril0

Todd L. Graybill0

Yunfeng Lan0

...

Date of Patent

July 5, 2022

Patent Application Number

166522210

Date Filed

October 4, 2018

Patent Citations

‌

US Patent 10981901 Heterocyclic amides useful as protein modulators

‌

US Patent 10189820 Heterocyclic amides useful as protein modulators

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11377440 Modulators of stimulator of interferon genes (STING)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API